Serotonin and Mental Disorders: A Concise Review on Molecular Neuroimaging Evidence
Clinical Psychopharmacology and Neuroscience
;
: 196-202, 2014.
Article
in English
| WPRIM
| ID: wpr-171400
ABSTRACT
Serotonin is one of the most important neurotransmitters influencing mental health and, thus, is a potential target for pharmaco-logical treatments. Functional neuroimaging techniques, such as positron-emission tomography (PET) and single photon emission computed tomography (SPECT), could provide persuasive evidence for the association between mental disorders and serotonin. In this concise review, we focus on evidence of the links between serotonin and major depressive disorders, as well as other mood disorders, anxiety disorders, schizophrenia, addiction, attention deficit hyperactivity disorder (ADHD), and autism.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Anxiety Disorders
/
Schizophrenia
/
Attention Deficit Disorder with Hyperactivity
/
Autistic Disorder
/
Serotonin
/
Tomography, Emission-Computed, Single-Photon
/
Mental Health
/
Neurotransmitter Agents
/
Mood Disorders
/
Positron-Emission Tomography
Type of study:
Diagnostic study
Language:
English
Journal:
Clinical Psychopharmacology and Neuroscience
Year:
2014
Type:
Article
Similar
MEDLINE
...
LILACS
LIS